Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens

Diagnostic Microbiology and Infectious Disease

Volumn 48, Issue 4, 2004, Pages 283-286

  Dan, M ^a   Keynan, O ^a   Feldbrin, Z ^a   Poch, F ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Bactericidal activity; Moxifloxacin; Serum; Synovial fluid

Indexed keywords

MOXIFLOXACIN;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM DETECTION; BIOASSAY; CLINICAL ARTICLE; DRUG TISSUE LEVEL; EX VIVO STUDY; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; KLEBSIELLA PNEUMONIAE; KNEE ARTHROSCOPY; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; SYNOVIAL FLUID;

ADMINISTRATION, ORAL; AGED; ARTHRITIS, INFECTIOUS; AZA COMPOUNDS; BACTERIA; BLOOD BACTERICIDAL ACTIVITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; QUINOLINES; SYNOVIAL FLUID;

EID: 1942455938     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2003.10.013     Document Type: Article

References (16)

1. Barman Balfour J.A., Wiseman L.R. Moxifloxacin. Drugs. 57:1999;363-373.
2. Bennet J.V. Simplified accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 14:1966;170-177.
3. Entanza J.M., Que Y.A., Vouillamoz J., Glauser M.P., Moreillon P. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob Agents Chemother. 45:2001;3076-3083.
4. Klastersky J., Daneau D., Swings D.G., Weerts D. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis. 129:1974;187-193.
5. Lister, P. D. (2001) Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmocokinetic model. Clin Infect Dis 32 (Suppl. 1), S33-S38.
6. Muller-Serieys, C., Delrre, D., Benoit, C., Bigot, C., Maubert, Carbon, C. (1999) Levofloxacin: serum bactericidal activity against methicillin- resistant staphylococcal isolates. J Antimicrob Chemother 43 (Suppl. C), 67-70.
7. National Committee for Clinical Laboratory Standards. (1999) Methodology for Serum Bactericidal Tests. M21-A. NCCLS, Villanova, PA.
8. National Committee for Clinical Laboratory Standards. (2002) Performance Stands for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. M100-S12. NCCLS, Villanova, PA
9. Odenholt I., Lowdin E., Gustafsson I., Cars O. Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model. Antimicrob Agents Chemother. 46:2002;2046-2048.
10. Preston S.L., Drusano G.L., Berman A.L., et al. Pharmacodynamics of levofloxacin a new paradigm for early clinical trials. JAMA. 279:1998;125-129.
11. Rodriguez-Cerrato V., McCoig C.C., Michelow J.C., Ghaffar F., Jafri H.S., Hardy R.D., Patel C., Olsen K., McCracken G.H. Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis. Antimicrob Agents Chemother. 45:2001;3092-3097.
12. Schentag J.J., Gilliland K.K., Paladino J.A. What have we learned from pharmacokinetic and pharmacodynamic theories. Clin Infect Dis. 32:(Suppl 1):2001;S39-S46.
13. Weinstein M.P., Stratton C.W., Ackley A., Hawley H.B., Robinson P.A., Fisher B.D., et al. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med. 78:1985;262-269.
14. Weinstein M.P., Stratton C.W., Hawley H.B., Ackley A., Reller L.B. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med. 83:1987;218-222.
15. Wise R. A review of the clinical pharmacology of moxifloxacin, a new 8-methoxyquinolone, and its potential relation to therapeutic efficacy. Clin Drug Invest. 17:1999;365-387.
16. Wolfson J.S., Swartz M.N. Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med. 312:1985;968-975.